Pricing
Login
Home
Charts
Search
Watchlist
Products

Bliss GVS Pharma Ltd

BLISSGVS
₹640.55-3.73%20 Nov 2026
Reports
Pharma Formulations

Bliss GVS Pharma Ltd

BLISSGVS
₹640.55
-3.73%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹6,814Cr
Close
Close Price
₹640.55
Industry
Industry
Pharma Formulations
PE
Price To Earnings
42.09
PS
Price To Sales
6.34
Revenue
Revenue
₹1,074Cr
Rev Gr TTM
Revenue Growth TTM
24.87%
PAT Gr TTM
PAT Growth TTM
44.27%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
201198184218210198207244218257286313
Growth YoY
Revenue Growth YoY%
-2.47.215.12.74.8-0.113.012.33.729.837.628.2
Expenses
ExpensesCr
157170149176181177166201183213209233
Operating Profit
Operating ProfitCr
442834413021414335447681
OPM
OPM%
21.814.318.719.114.210.719.917.815.917.326.825.7
Other Income
Other IncomeCr
5-244515123581611108
Interest Expense
Interest ExpenseCr
222412531213
Depreciation
DepreciationCr
77778888891011
PBT
PBTCr
40-430363623634141457575
Tax
TaxCr
11181011719121682422
PAT
PATCr
29-522262617442925375153
Growth YoY
PAT Growth YoY%
-2.4-241.953.9-40.3-11.3439.1100.611.3-4.0122.215.886.6
NPM
NPM%
14.5-2.512.011.812.38.421.411.711.314.418.017.0
EPS
EPS₹
2.6-0.92.02.32.31.54.12.62.23.44.74.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
201198184218210198207244218257286313
Growth YoY
Revenue Growth YoY%
-2.47.215.12.74.8-0.113.012.33.729.837.628.2
Expenses
ExpensesCr
157170149176181177166201183213209233
Operating Profit
Operating ProfitCr
442834413021414335447681
OPM
OPM%
21.814.318.719.114.210.719.917.815.917.326.825.7
Other Income
Other IncomeCr
5-244515123581611108
Interest Expense
Interest ExpenseCr
222412531213
Depreciation
DepreciationCr
77778888891011
PBT
PBTCr
40-430363623634141457575
Tax
TaxCr
11181011719121682422
PAT
PATCr
29-522262617442925375153
Growth YoY
PAT Growth YoY%
-2.4-241.953.9-40.3-11.3439.1100.611.3-4.0122.215.886.6
NPM
NPM%
14.5-2.512.011.812.38.421.411.711.314.418.017.0
EPS
EPS₹
2.6-0.92.02.32.31.54.12.62.23.44.74.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5477988158996895777477527708109271,074
Growth
Revenue Growth%
34.346.02.010.3-23.3-16.329.50.62.55.114.524.9
Expenses
ExpensesCr
391596618741566471629634620683763838
Operating Profit
Operating ProfitCr
156203197158123107118117151127164236
OPM
OPM%
28.525.424.217.517.918.515.815.619.615.717.722.0
Other Income
Other IncomeCr
2413-8382620-42180367145
Interest Expense
Interest ExpenseCr
19202348651078127
Depreciation
DepreciationCr
13202191317171926293337
PBT
PBTCr
14817514518212910454106117126190236
Tax
TaxCr
486357553430312935355570
PAT
PATCr
10011389127957423778290135166
Growth
PAT Growth%
63.112.5-21.342.9-24.8-22.3-68.7231.86.310.649.344.3
NPM
NPM%
18.314.110.914.113.812.83.110.210.611.214.515.5
EPS
EPS₹
8.08.05.712.09.46.61.56.87.28.012.215.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5477988158996895777477527708109271,074
Growth
Revenue Growth%
34.346.02.010.3-23.3-16.329.50.62.55.114.524.9
Expenses
ExpensesCr
391596618741566471629634620683763838
Operating Profit
Operating ProfitCr
156203197158123107118117151127164236
OPM
OPM%
28.525.424.217.517.918.515.815.619.615.717.722.0
Other Income
Other IncomeCr
2413-8382620-42180367145
Interest Expense
Interest ExpenseCr
19202348651078127
Depreciation
DepreciationCr
13202191317171926293337
PBT
PBTCr
14817514518212910454106117126190236
Tax
TaxCr
486357553430312935355570
PAT
PATCr
10011389127957423778290135166
Growth
PAT Growth%
63.112.5-21.342.9-24.8-22.3-68.7231.86.310.649.344.3
NPM
NPM%
18.314.110.914.113.812.83.110.210.611.214.515.5
EPS
EPS₹
8.08.05.712.09.46.61.56.87.28.012.215.2
Sales CAGR
1 Year14%
3 Years7%
5 Years10%
TTM25%
EBITDA CAGR
1 Year29%
3 Years12%
5 Years9%
TTM74%
PAT CAGR
1 Year49%
3 Years21%
5 Years13%
TTM44%
Avg. ROCE
1 Year17%
3 Years13%
5 Years12%
TTM19%
CFO / EBITDA
1 Year85%
3 Years79%
5 Years76%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
101010101010101010111111
Reserves
ReservesCr
4024765266367257988088739571,0401,1821,280
Current Liabilities
Current LiabilitiesCr
267437299207231204233193157172236230
Non Current Liabilities
Non Current LiabilitiesCr
503313384645294651372521
Total Liabilities
Total LiabilitiesCr
7621,0238609051,0271,0771,1091,1571,2121,3011,4921,582
Current Assets
Current AssetsCr
471566690693770765777697811824946999
Non Current Assets
Non Current AssetsCr
291457170211257312332459401477546583
Total Assets
Total AssetsCr
7621,0238609051,0271,0771,1091,1571,2121,3011,4921,582
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
101010101010101010111111
Reserves
ReservesCr
4024765266367257988088739571,0401,1821,280
Current Liabilities
Current LiabilitiesCr
267437299207231204233193157172236230
Non Current Liabilities
Non Current LiabilitiesCr
503313384645294651372521
Total Liabilities
Total LiabilitiesCr
7621,0238609051,0271,0771,1091,1571,2121,3011,4921,582
Current Assets
Current AssetsCr
471566690693770765777697811824946999
Non Current Assets
Non Current AssetsCr
291457170211257312332459401477546583
Total Assets
Total AssetsCr
7621,0238609051,0271,0771,1091,1571,2121,3011,4921,582

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1132891840476413534103106139
Investing Cash Flow
Investing Cash FlowCr
-50-23150-74-48-47-93-8-83-76-38
Financing Cash Flow
Financing Cash FlowCr
-40-10-7617-6-21-24-25-21-30-89
Net Cash Flow
Net Cash FlowCr
2348-8-17-8-4192-1011
Free Cash Flow
Free Cash FlowCr
100186-72-125563-59753384
CFO To PAT
CFO To PAT%
112.8256.919.931.549.086.5585.844.7126.0117.3103.0
CFO To EBITDA
CFO To EBITDA%
72.5142.88.925.337.960.0114.529.368.383.684.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1132891840476413534103106139
Investing Cash Flow
Investing Cash FlowCr
-50-23150-74-48-47-93-8-83-76-38
Financing Cash Flow
Financing Cash FlowCr
-40-10-7617-6-21-24-25-21-30-89
Net Cash Flow
Net Cash FlowCr
2348-8-17-8-4192-1011
Free Cash Flow
Free Cash FlowCr
100186-72-125563-59753384
CFO To PAT
CFO To PAT%
112.8256.919.931.549.086.5585.844.7126.0117.3103.0
CFO To EBITDA
CFO To EBITDA%
72.5142.88.925.337.960.0114.529.368.383.684.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,3081,8202,0151,8561,0401,0187987421,1791,2392,2806,814
Price To Earnings
Price To Earnings
15.822.234.315.010.714.953.110.515.614.717.642.1
Price To Sales
Price To Sales
2.42.32.52.11.51.81.11.01.51.52.56.3
Price To Book
Price To Book
3.23.73.82.91.41.31.00.81.21.21.95.3
EV To EBITDA
EV To EBITDA
8.59.310.311.78.59.36.26.37.18.813.028.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.152.849.430.434.240.044.844.046.645.450.250.2
OPM
OPM%
28.525.424.217.517.918.515.815.619.615.717.722.0
NPM
NPM%
18.314.110.914.113.812.83.110.210.611.214.515.5
ROCE
ROCE%
32.527.925.925.116.211.86.311.811.611.816.618.9
ROE
ROE%
24.323.216.519.612.99.22.88.78.48.611.312.9
ROA
ROA%
13.211.010.314.09.36.92.16.66.76.99.010.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,3081,8202,0151,8561,0401,0187987421,1791,2392,2806,814
Price To Earnings
Price To Earnings
15.822.234.315.010.714.953.110.515.614.717.642.1
Price To Sales
Price To Sales
2.42.32.52.11.51.81.11.01.51.52.56.3
Price To Book
Price To Book
3.23.73.82.91.41.31.00.81.21.21.95.3
EV To EBITDA
EV To EBITDA
8.59.310.311.78.59.36.26.37.18.813.028.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.152.849.430.434.240.044.844.046.645.450.250.2
OPM
OPM%
28.525.424.217.517.918.515.815.619.615.717.722.0
NPM
NPM%
18.314.110.914.113.812.83.110.210.611.214.515.5
ROCE
ROCE%
32.527.925.925.116.211.86.311.811.611.816.618.9
ROE
ROE%
24.323.216.519.612.99.22.88.78.48.611.312.9
ROA
ROA%
13.211.010.314.09.36.92.16.66.76.99.010.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr10,9588,9177,6126,8146,1475,0244,284
Close PriceClose₹696.20967.30269.40640.55377.551,090.804,128.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE29.3014.4642.0919.6235.5244.67
Price To SalesPS2.271.71836.516.342.696.996.86
RevenueRevenueCr4,8265,21391,0742,289719624
Revenue Growth TTMRev Gr TTM%17.5%11.3%55.0%24.9%10.2%39.0%47.7%
PAT Growth TTMPAT Gr TTM%12.8%54.3%-80.3%44.3%39.0%60.2%95.7%
Market CapitalizationMkt CapCr10,9588,9177,6126,8146,1475,0244,284
Close PriceClose₹696.20967.30269.40640.55377.551,090.804,128.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE29.3014.4642.0919.6235.5244.67
Price To SalesPS2.271.71836.516.342.696.996.86
RevenueRevenueCr4,8265,21391,0742,289719624
Revenue Growth TTMRev Gr TTM%17.5%11.3%55.0%24.9%10.2%39.0%47.7%
PAT Growth TTMPAT Gr TTM%12.8%54.3%-80.3%44.3%39.0%60.2%95.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Load More
Interviews